ArticleBMC public health2025
Temporal trends in heart failure burden among young adults in China: a systematic analysis from 1990 to 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundStudies from several countries have reported an increasing trend in heart failure (HF) among young adults, but comprehensive data on HF burden among young Chinese adults are lacking.
methodsUsing data from the Global Burden of Disease Study 2021, we analyzed trends in prevalence and years lived with disability (YLDs) of HF among Chinese adults aged 20-49 years from 1990 to 2021. We examined age-standardized rates per 100,000 population, stratified by age groups, sex, severity levels, and underlying causes. Joinpoint regression, age-period-cohort analysis, decomposition analysis, frontier analysis and projection models were applied.
resultsFrom 1990 to 2021, HF prevalence cases increased from 448,261.89 to 897,595.61, while YLDs rose from 44,025.76 to 88,416.28. Age-standardized prevalence rates increased from 88.44 to 141.27 per 100,000 population, and YLD rates increased from 8.70 to 13.90, with average annual percentage changes (AAPC) of 1.53 (95% CI: 1.40-1.65) and 1.52 (95% CI: 1.42-1.61), respectively. Ischemic heart disease remained the leading cause (51.68 per 100,000), followed by hypertensive heart disease (29.25) and cardiomyopathy (15.83), while atrial fibrillation showed the highest relative increase (446%). Frontier analysis revealed a moderate gap (effective difference: 51.68) between China's current and potentially achievable HF prevalence. Epidemiological changes (66.9%) drove the increased burden, with projections indicating continued rises through 2030.
conclusionsThe burden of HF among young Chinese adults has increased substantially over the past three decades, with traditional cardiovascular causes remaining predominant. These findings highlight the urgent need for enhanced prevention strategies targeting young adults in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.